Supplier profile
FARMACEUTICA PARAGUAYA S.A.
Every public-sector award we hold for this supplier, across Paraguay, from 30 Mar 2010 to 17 Jul 2026.
Awards won
319
all time
Attributed value
PYG 1067.8bn
as published
Buyers
15
public bodies
Active
2010–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Ministerio de Salud Pública y Bienestar Social (MSPBS) | 119 | PYG 625.8bn |
| Instituto de Previsión Social (IPS) | 88 | PYG 420.6bn |
| Universidad Nacional de Asunción (UNA) | 34 | PYG 8.1bn |
| Dirección de Beneficencia (DIBEN) | 18 | PYG 6.0bn |
| Presidencia de la República | 15 | PYG 3.5bn |
| Ministerio del Interior (M.I.) | 14 | PYG 2.5bn |
| Ministerio de Defensa Nacional (MDN) | 11 | PYG 599.6m |
| Gobierno Departamental de Itapua (ITAPÚA) | 5 | PYG 315.6m |
| Ministerio de Justicia (MJ) | 5 | PYG 177.5m |
| Gobierno Departamental de Cordillera (CORDILLERA) | 3 | PYG 35.1m |
What they win
Awards
Showing 76–100 of 319 awards we hold
- ADQUISICIÓN DE MEDICAMENTOS ONCOLÓGICOS DARCABACINA 200 MG Y GEMCITABINA 1 MG.PARA EL INCAN Y OTROS CENTROS ONCOLÓGICOS DEL MSPYBS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 898.0mawarded 1 Nov 2022
- CVE 9-21 ADQUISICION POR URGENCIA IMPOSTERGABLE DE MEDICAMENTOS VARIOS PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 340.5mawarded 29 Oct 2022
- CVE 44-21 ADQUISICIÓN URGENTE DE MEDICAMENTOS DESGLOSADOS PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 4.2bnawarded 13 Oct 2022
- CVE N° 10/2022 - ADQUISICIÓN DE MEDICAMENTOS ALECTINIB 150MG, ADALIMUMAB 40 MG/0,4ML, ADALIMUMAB 40 MG/0,8ML, OCRELIZUMAB 300 MG, SUNITINIB 50 MG, PALBOCICLIB 125 MG - AMPARO. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 164.6mawarded 5 Oct 2022
- CVE 64/21 ADQUISICIÓN URGENTE DE MEDICAMENTOS CON STOCK CRITICO PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 506.9mawarded 29 Sept 2022
- CVE 85/21-ADQUISICION DE ADALIMUMAB - AMPARO JUDICIAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 149.9mawarded 27 Sept 2022
- CVE N° 82/21 ADQUISICIÓN DE ADALIMUMAB INYECTABLE 40 MG/0,8 ML - AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 149.9mawarded 21 Sept 2022
- LPN SBE 103-19 ADQUISICION DE MEDICAMENTOS VARIOS PARA EL IPS - AD REFERENDUM 2020 ↗Instituto de Previsión Social (IPS)PYG 3.8bnawarded 15 Sept 2022
- CVE 95-20 ADQUISICION URGENTE DEL MEDICAMENTO ENZALUTAMIDA 40 MG PARA ANGEL TALAVERA RODRIGUEZ ↗Instituto de Previsión Social (IPS)PYG 265.7mawarded 18 Aug 2022
- ADQUISICIÓN DE MEDICAMENTO ONCOLÓGICO TEMOZOLAMIDA 100 MG PARA EL INCAN Y OTROS CENTROS ONCOLÓGICOS DEL MSPYBS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 1.5bnawarded 3 Aug 2022
- LPN N° 103/21 ADQUISICIÓN DE MEDICAMENTOS PARA PACIENTES AUTOINMUNES DEL MSPYBS -AD-REFERENDUM ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 6.7bnawarded 14 Jul 2022
- CVE 16/22 - "ADQUISICIÓN DE MEDICAMENTO BACILO CALMETTE GUERIN 40MG, PAZOPANIB 400MG, TEMOZOLAMIDA 100MG, TEMOZOLAMIDA 20MG, NIVOLUMAB 100MG, ABIRATERONA ACETATO 250MG, PALBOCICLIB 100MG, PACLITAXEL 100MG, SUNITINIB 50MG - AMPARO" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 323.5mawarded 5 Jul 2022
- CVE 24-21 ADQUISICION URGENTE DE MEDICAMENTOS BIOLOGICOS, BIOTECNOLOGICOS, ONCOLOGICOS E INMUNOSUPRESORES PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 4.2bnawarded 1 Jul 2022
- ADQUISICION DE MEDICAMENTOS PARA EL HOSPITAL DE CLINICAS - AD REFERENDUM 2022 ↗Universidad Nacional de Asunción (UNA)PYG 609.5mawarded 27 Jun 2022
- CVE N° 79/21 ADQUISICIÓN ATEZOLIMUMAB 840 MG Y NAB PACLITAXEL 100 MG - AMPARO JUDICIAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 296.6mawarded 25 May 2022
- LPN N° 83/21 ADQUISICIÓN DE MEDICAMENTOS VARIOS PARA EL MSBYBS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 596.5mawarded 10 May 2022
- CVE 25/21 ADQUISICION URGENTE DE MEDICAMENTOS VARIOS PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 274.5mawarded 6 May 2022
- CVE N° 11/2022 ADQUISICIÓN DE MEDICAMENTO ONCOLÓGICO NAB PACLITAXEL INYECTABLE 100 MG - AMPARO. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 175.8mawarded 19 Apr 2022
- CVE N° 89/21 ADQUISICIÓN DE PALBOCICLIB 125 MG; FULVESTRANT 250 MG; IPILIMUMAB 50 MG; NIVOLUMAB 100 MG; ATEZOLIZUMAB 840 MG; PACLITAXEL 100 MG; ABEMACICLIB 150 MG ? AMPARO. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 97.5mawarded 11 Apr 2022
- LPN 99-19 ADQUISICION DE MEDICAMENTOS DESGLOSADOS DECLARADOS DESIERTOS EN LA LPN Nº 24/19 Y OTROS PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 3.3bnawarded 8 Apr 2022
- LPN SBE 130-21 ADQUISICION DE MEDICAMENTOS MONOCLONALES PARA EL IPS ↗Instituto de Previsión Social (IPS)PYG 1.4bnawarded 16 Mar 2022
- LPN N° 39/21 - ADQUISICIÓN DE MEDICAMENTOS PARA LA DIRECCIÓN DE SALUD MENTAL, HOSPITAL PSIQUIÁTRICO, INSTITUTO DE BIENESTAR SOCIAL, CENTRO NACIONAL DE ADICCIONES Y OTROS SERVICIOS DEL MSPBS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 4.4bnawarded 26 Jan 2022
- LPN SBE N° 69/21 "ADQUISICIÓN DE MEDICAMENTOS PARA PERSONAS AFECTADAS CON EL SÍNDROME DE ESCLEROSIS MÚLTIPLE" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 783.6mawarded 20 Jan 2022
- CD 40/2021- ADQUISICIÓN DE ADALIMUMAB 40 MG/ 0,8 ML AMPOLLA - AMPARO CONSTITUCIONAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 174.5mawarded 14 Dec 2021
- ADQUISICION DE MEDICAMENTOS ONCOLOGICOS PARA EL INCAN Y OTROS CENTROS ONCOLOGICOS DEL MSP Y BS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 861.0mawarded 9 Dec 2021
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.